Vioser
- Company typePrivate
- Founded1980
- HeadquartersTaxiárkhis, Greece
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Vioser firmographics
Firmographics- Name
- Vioser
- Legal name
- Vioser S.A.
- Website
- https://bioser.gr
- Company type
- Private
- Founded year
- 1980
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Where Vioser is headquartered
LocationHeadquarters
- HQ city
- Taxiárkhis
- HQ country
- Greece
- HQ region
- Europe
Offices3 records
Markets served
Vioser business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Infrastructure, Technology or R&D, Personnel, Operations
Revenue model
- Pharmaceutical Products: Production and sale of sterile parenteral solutions (IV solutions, irrigation solutions, urological products) and medical devices (infusion and transfusion sets). The company holds a dominant position in the Greek market and exports to international markets.
- Contract Manufacturing: Custom manufacturing of IV solutions for international pharmaceutical companies. VIOSER possesses the know-how and flexibility to produce any type of IV solution suitable to specific market needs. International companies absorb more than 30% of total production.
- Distribution/Representation: Exclusive representation in Greece of B.Braun Melsungen AG Hospital Care products and Ecolab's Skinman Complete antiseptic solution, distributing pharmaceutical and medical device products from European and American manufacturers.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels2 records
Vioser product offering
Product offeringCore offering
Vioser manufactures and sells sterile parenteral solutions (IV electrolyte, carbohydrate, and antibiotic solutions), polyethylene containers produced by Blow-Fill-Seal (Bottlepack®) technology, irrigation and urology solutions, and IV administration sets (Vioset line). The company serves Greek hospitals and healthcare facilities directly and provides contract manufacturing of custom IV solutions for international pharmaceutical companies across Europe, Asia, and Africa.
Product overview
Vioser is a Greek pharmaceutical company specializing in parenteral solutions, offering a comprehensive portfolio of sterile IV products. The core product line consists of Solutions (electrolyte, carbohydrate, and antibiotic IV solutions in 100-1000ml volumes), PE Containers (round and oval shaped bottles using Blow-Fill-Seal technology), Irrigation Solutions (500-1000ml), Large Volume Urology Solutions (2-3 liter PVC bags), and Vioset IV Administration Sets. All products are manufactured under GMP standards with CE marking, serving both domestic and international markets through contract manufacturing services.
Differentiator
Problem solved
Functional benefit
Products and services
- Electrolyte Solutions (IV) Parenteral electrolyte IV solutions including Sodium Chloride 0.9%, 7.5%, and 15%; Ringer's Solution; and Lactated Ringer's (Hartmann's Solution), available in 100, 250, 500, and 1000 ml volumes. Intended for hospitals and healthcare facilities for fluid and electrolyte replacement therapy.
- Carbohydrate Solutions (IV) Carbohydrate-based IV solutions including Sodium Chloride with Dextrose combinations, Potassium Chloride in Dextrose, Dextrose at concentrations from 5% to 50%, Mannitol 20%, and Water For Injections. Designed for clinical fluid and nutritional therapy in hospital settings.
- Pre-mixed Antibiotic IV Solutions Pre-mixed antibiotic IV solutions including Metronidazole 500mg/100ml and Moxifloxacin 400mg/250ml, ready-to-administer for hospital antimicrobial therapy.
- Round-Shaped PE Containers Round-shaped polyethylene containers manufactured using Blow-Fill-Seal (Bottlepack®) technology for sterile, pyrogen-free large-volume infusion solutions, available in volumes from 100ml to 1000ml. Non-fragile, easy to store, cost-effective with long shelf life and no overwrap required.
- Oval-Shaped PE Containers with Twin Port Closure Twin port closure oval-shaped PE containers featuring twist-off caps, easy storage, convenience, twin port for infusion and additions, free space for drug addition, and no residual volume, available in volumes from 100ml to 1000ml.
- Irrigation Solutions Sterile, pyrogen-free irrigation solutions in neutral plastic PE containers produced by Blow-Fill-Seal technology, available in 500ml to 1000ml volumes with twist-off caps and no residual volume, for use in surgical and clinical irrigation.
- Large Volume Urology Solutions Sterile, pyrogen-free urology and irrigation solutions for intra-operative and post-operative use, packaged in Medical Grade PVC bags with protective overwrap (PE/PA/PP), available in 2 and 3 liters with special connectors and suspension systems.
- Vioset IV Administration Sets Intravenous and transfusion administration sets including Vioset 2 (standard IV), Vioset 3 (transfusion), Vioset 5 (volume control with burette), Vioset 6 (opaque for light-sensitive solutions), and Vioset 8 (with flow regulator), featuring PVC-free drip chambers, DEHP-free medical-grade PVC tubing, and Luer Lock fitting, meeting ISO 8536-4, ISO 1135-4, and ISO 8536-5 standards.
- Contract Manufacturing Services Custom manufacturing of IV solutions and medical devices for international pharmaceutical companies using proprietary Bottlepack® technology. Vioser produces any type of IV solution suitable to specific market and regulatory needs for partners across Europe, Asia, and Africa, with international companies absorbing more than 30% of total production.
Quantifiable outcome
- More than 30% of total production absorbed by international companies
- +2 more outcomes
Companies that use Vioser
Customer profileSegments2 records
Ideal customer profiles2 records
Vioser technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Vioser partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- B.Braun Melsungen AG – Hospital CarecoreVioser is the exclusive representative in Greece for B.Braun Melsungen AG Hospital Care products. The partnership covers clinical nutrition, anesthetics, volume substitutes, antibiotics (pharmaceuticals) and regional anesthesia, infusion consumables, pumps, peripheral catheters, and central catheters (medical devices).
- EcolabminorVioser represents Ecolab's Skinman Complete antiseptic solution in Greece. Ecolab is an American pharmaceutical/medical devices company.
Scale indicators5 records
Recent moves11 records
Expansion highlights5 records
Vioser competitors and assessment
Company assessmentDirect peers
- Baxter International: Major manufacturer of IV solutions, irrigation fluids, and sterile injectable pharmaceuticals. Direct peer across Vioser's entire core product range including flexible bags and large-volume containers.
- ICU Medical: Manufacturer of IV therapy products including administration sets, needlefree connectors, and infusion pumps. Direct peer for Vioset's IV administration set portfolio.
- Terumo Corporation: Japanese medical device manufacturer with strong IV administration sets, syringes, and blood transfusion product lines. Comparable in infusion/transfusion medical devices.
- B. Braun Melsungen AG: Global manufacturer of IV solutions, infusion sets, and sterile medical devices. Direct peer in large-volume parenterals and infusion consumables; also a partner of Vioser for Greek distribution.
- Fresenius Kabi: One of the world's largest producers of generic IV solutions, infusion therapies, and clinical nutrition. Competes head-to-head with Vioser in sterile parenteral solutions across Europe and emerging markets.
Emerging players
- Polymedicure: Indian medical device company specializing in IV cannula, infusion sets, and blood transfusion sets. Direct competitor in the IV administration set segment where Vioset competes.
- Grifols: Spanish pharmaceutical company with hospital IV solutions, parenteral nutrition, and sterile manufacturing capabilities. Regional peer with comparable product portfolio to Vioser's parenteral solutions business.
Broad incumbents
- Becton Dickinson (BD): Global medical technology incumbent with broad portfolio including IV drug delivery, infusion therapy, and prefilled syringe systems. Comparable medical-device manufacturing scale and regulatory depth.
Regional players
- Demo Pharmaceuticals: Greek pharmaceutical manufacturer of sterile injectables, IV solutions, and hospital products. Regional peer operating in the same domestic market with directly overlapping product categories.
- Eurolife Healthcare: Indian manufacturer of IV infusions, injectables, and sterile medical devices. Comparable in BFS-based sterile manufacturing for emerging markets; competes with Vioser for international contract manufacturing opportunities.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Vioser social profiles
Digital presenceVioser compliance and trust
Trust signalCompliance6 records
Vioser financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vioser leadership team
Management profileNumber of profiles
Profiles1 record
Vioser funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vioser M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vioser
What does Vioser do?
Vioser manufactures and sells sterile parenteral solutions (IV electrolyte, carbohydrate, and antibiotic solutions), polyethylene containers produced by Blow-Fill-Seal (Bottlepack®) technology, irrigation and urology solutions, and IV administration sets (Vioset line). The company serves Greek hospitals and healthcare facilities directly and provides contract manufacturing of custom IV solutions for international pharmaceutical companies across Europe, Asia, and Africa.
Is Vioser a public or private company?
Vioser is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vioser founded?
Vioser was founded in 1980. It employs 251 to 500 people.
Where is Vioser based?
Vioser is headquartered in Taxiárkhis, Greece, in the Europe region.
How does Vioser make money?
Three revenue lines are on record. Pharmaceutical Products are the primary driver. The others are contract Manufacturing and distribution/Representation.
Who are Vioser's main competitors?
Direct peers on record are Baxter International, ICU Medical, Terumo Corporation, B. Braun Melsungen AG and Fresenius Kabi. Emerging players are Polymedicure and Grifols. Becton Dickinson (BD) is listed as a broad incumbent. Regional players are Demo Pharmaceuticals and Eurolife Healthcare.
Does Vioser have an API?
No public API is recorded for Vioser.